Emerging Bcl-2 inhibitors for the treatment of cancer

By Azmi Asfar S   Wang Zhiwei   Philip Philip A   Mohammad Ramzi M   Sarkar Fazlul H  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 1, 2011-03 ,pp. : 59-70

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for targeted therapy of bladder cancer

By Agarwal Piyush K   Black Peter C   McConkey David J   Dinney Colin PN  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 435-448

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu   Quinn Bridget A   Das Swadesh K   Dash Rupesh   Emdad Luni   Dasgupta Santanu   Wang Xiang-Yang   Dent Paul   Reed John C   Pellecchia Maurizio   Sarkar Devanand   Fisher Paul B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

Emerging cell-cycle inhibitors for pancreatic cancer therapy

By Bayraktar Soley  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 571-582

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy

By  

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-11 ,pp. : 244-254

Bentham Science Publishers

Access to resources Recommend Favorite